Objective: To evaluate the results of two operations, aortic valve-sparing and aortic root replacement, in patients with aortic root aneurysm and the Marfan syndrome. Methods: A retrospective review of 78 consecutive patients with aortic root aneurysm and the Marfan syndrome according to the Gent criteria indicated that 42 patients with normal aortic cusps had an aortic valve-sparing operation, and 36 patients had aortic root replacement (mechanical valve in 25 patients and biological valve in 11). The mean age was similar in both groups, but patients who had aortic root replacement had larger aneurysms, higher grade aortic insuf®ciency, worse left ventricular function and more cardiac co-morbidity than patients who had aortic valve-sparing operations. The mean follow-up was 41^35 months for patients who had aortic valve-sparing, and 65^50 months for those who had aortic root replacement. Results: Kaplan±Meyer estimates of survival at 5 years was 100% for patients who had aortic valve-sparing, and 88^6% for those who had aortic root replacement (P 0:04). Five patients who had aortic root replacement required seven aortic root re-replacements: three for endocarditis and four for valve failure (biological valves). There have been no reoperations in patients who had aortic valve-sparing operations and annual Doppler echocardiography revealed mild or no aortic insuf®ciency in 39 patients and moderate aortic insuf®ciency in three. Conclusions: These data suggest that aortic valve-sparing operations are safe in patients with the Marfan syndrome and may provide better clinical outcomes than aortic root replacement. Since the size of the aneurysm often determines the feasibility of a valve-sparing procedure, we now recommend surgery when the diameter of the aortic root reaches 50 mm in patients with the Marfan syndrome who have echocardiographically normal aortic valve cusps. q
Introduction
Modern cardiac surgery dramatically changed the natural history of patients with the Marfan syndrome [1±3] . In 1968, Bentall and DeBono described an operative procedure whereby the aortic root and ascending aorta were replaced with a tubular Te¯on graft containing a mechanical heart valve, and the coronary arteries were reimplanted by suturing the graft to the aortic sinus wall around their ori®ces [2] . Although certain aspects of that procedure were modi®ed to minimize operative and late complications, composite replacement of the aortic valve and ascending aorta with reimplantation of the coronary arteries remains the standard operation for patients with aortic root aneurysm and the Marfan syndrome [3] . In 1992, David and Feindel described a method of reconstruction of the aortic valve in patients with aortic root aneurysm, whereby the three sinuses of Valsalva and the ascending aorta were excised, and the aortic valve was re-implanted inside a tubular Dacron graft [4] . This and other types of aortic valve-sparing operations are alternative procedures to the composite replacement of the aortic valve and ascending aorta in patients with aortic root aneurysm and macroscopically normal aortic valve cusps [5] . Many surgeons believe that aortic valvesparing operations should not be used in patients with the Marfan syndrome [3] . We believe that both the aortic and the mitral valve of patients with the Marfan syndrome should be preserved whenever possible, and have adopted this approach in our practices over the past decade.
This study is a review of our experience with surgery of the aortic root in patients with the Marfan syndrome.
Patients and methods
From 1979 to 1998, 78 consecutive patients with the Marfan syndrome according to Gent criteria [6] had surgery for aortic root aneurysm at Toronto General Hospital. There were 61 men and 17 women. The mean age of the patients was 35 years (range, 16±70). The operation was performed electively in 63 patients and as an emergency in 15 (acute type A aortic dissection in 14 patients and cardiogenic shock in one).
Aortic valve-sparing operations were performed in 42 patients and composite replacement of the aortic valve and ascending aorta in 36. Aortic valve-sparing operations have been performed only since May 1988 and in patients with normal or mildly diseased aortic valve cusps. Composite replacement of the aortic valve and ascending aorta was performed throughout the period of study, and since 1988, only in patients with grossly abnormal aortic cusps. Table 1 shows the preoperative characteristics of patients who had aortic valve-sparing operations and those who had aortic root replacement. Table 2 shows the operative data. Patients have been followed up at annual intervals and Doppler echocardiographic studies were obtained for those who had aortic valve-sparing operations. An annual CT scan of the chest and abdomen was also obtained in patients who had aortic dissection. The mean follow-up was 41^35 months (range, 5±133) for patients who had aortic valve-sparing operations, and 65^50 months (range, 3±216) for patients who had composite replacement of the aortic valve and ascending aorta. No patient was lost to follow-up.
Clinical and echocardiographic variables were entered in datasets using dBASEIV, and analyzed with the SAS for PC statistical program. Categorical variables were compared using Chi-square or Fisher's exact test where appropriate. Time-related events were evaluated univariately by the Kaplan±Meier method and log-rank statistic. Multivariable analysis was not performed because of the small sample size and too few events.
Results
There was one operative death in a patient who had an emergency operation because of cardiogenic shock due to end-stage aortic insuf®ciency, severe left ventricular dysfunction, coarctation of the aorta and a massive aneurysm of the aortic root. A valved conduit was used for aortic root replacement. This patient died of myocardial failure.
Nine patients required re-exploration of the mediastinum for bleeding; ®ve patients in the valve-sparing group and 3 3 four in the root replacement group. There was no perioperative stroke, myocardial infarction, or any infection. There were four late deaths, all in the aortic root replacement group. The cause of late death was valve-related in two patients (one due to endocarditis and one sudden death, probably an acute myocardial infarction), and due to vascular complications in two patients (one rupture of the false lumen and one rupture of a true thoracic aneurysm). Fig. 1 shows the survival in both groups of patients. The survival at 5 years was 100% for patients who had aortic valvesparing operations and 88^6% for patients who had aortic root replacement (P 0:04).
There were no thromboembolic events in patients who had valve-sparing and there were two strokes in patients who had aortic root replacement with a mechanical aortic valve. Neither one of these patients had undergone mitral valve replacement. Both patients recovered completely.
There were four episodes of prosthetic valve endocarditis in three patients. One patient was deemed inoperable and died. He was an elderly man who had undergone two previous aortic root and mitral valve replacements and multiple co-morbid conditions. The other two patients underwent aortic root re-replacement and survived. One of them had endocarditis twice, 4 years apart. There were no major bleeding complications in patients on oral anticoagulants for mechanical aortic valves.
There were seven aortic root re-replacements in ®ve patients. Three reoperations were because of prosthetic valve endocarditis and four due to biological valve failure (two bioprostheses and two homografts). No patient died at reoperation. There was no reoperation in the aortic valvesparing group. Fig. 2 shows the freedom from reoperation; at 5 years it was 100% for patients who had aortic valvesparing and 89^6% for patients who had aortic root replacement (P 0:04).
Four patients, two from each group, required replacement of the entire thoracic and abdominal aorta because of expansion or rupture of the false lumen. One patient with a ruptured false lumen died. He had undergone aortic root replacement with a mechanical valve. Another patient became paraplegic. He had undergone an aortic valve-sparing operation. This last patient also needed replacement of the transverse aortic arch. The other two patients, one from each group, did well.
The most recent Doppler echocardiographic study in patients who had aortic valve-sparing operations showed no aortic insuf®ciency in six patients, trivial in 13, mild in 20, and moderate in three. These three patients with moderate aortic insuf®ciency had mildly elongated aortic cusps and required shortening of the their free margins with a 6-0 ePTFE suture (expanded polytetra¯uoroethylene), in addition to an aortic annuloplasty and remodeling of the aortic root.
Discussion
The standard treatment for aortic root aneurysm in patients with the Marfan syndrome is composite replacement of the aortic valve and ascending aorta [3] . This operation improved the poor prognosis of patients with aortic root aneurysm and the Marfan syndrome [1] . In a recent report by Gott et al. on the results of aortic root surgery in patients with the Marfan syndrome from multiple institutions, the operative mortality was 1.5% for elective operations and 11.7% for emergency operations [3] . The actuarial survival rates in that collective series were 84% at 5 years, and 75% at 10 years. Coincidentally, the long-term survival in our much smaller series of patients who had aortic root replacement is remarkably similar to that reported by Gott et al. [3] . Actually, our patients were included in that series.
Since 1988, we have been preserving the aortic valve in patients with aortic root aneurysms as long as the aortic cusps are normal or only minimally diseased. We have not excluded patients with the Marfan syndrome. The appropriateness of this operation in this group of patients has been controversial because many surgeons believe that the aortic cusps of patients with the Marfan syndrome are histologically abnormal. Indeed, histological studies by Fleischer et al. [7] revealed a high degree of structural deterioration in aortic cusps removed at the time of aortic root replacement in patients with the Marfan syndrome. Although we do not dispute those ®ndings, the experience with mitral valve repair in patients with myxomatous disease of the mitral valve, including those with the Marfan syndrome, indicates that histochemically-abnormal lea¯ets and chordae tendineae can last a long time if properly anchored by the surrounding structures [8, 9] . By analogy, the aortic valve cusps should not fail if the aortic annulus and the sinotubular junction are stabilized by corrective surgery [5] . It has been our experience that the aortic valve cusps of patients with the Marfan syndrome are remarkably normal when the aortic root aneurysm is not excessively large. However, as the aortic root dilates, the mechanical stress on the cusp increases and the degenerative process is accelerated. The cusps become thinner and elongated, and stress fenestrations appear in the commissural areas. These cusps should not be repaired and aortic root replacement is certainly the appropriate treatment. Most of these patients have aortic root diameters in excess of 55 mm. However, if surgery is performed before the aortic root reaches that size, the aortic cusps are frequently normal or only minimally stretched, and a valve-sparing operation is feasible and probably the best treatment for these patients.
In our study, the group of patients who had aortic valvesparing operations was different from the group who had aortic root replacement, as indicated in Table 1 . Patients who had aortic valve-sparing operations were less symptomatic, and had better left ventricular function, lower grade aortic insuf®ciency, fewer co-morbid conditions and smaller aortic root aneurysms than patients who had aortic root replacement. Although these differences may have played a role in the clinical outcomes, it is important to notice that patients who had aortic valve-sparing operations had no cardiac or valve-related events postoperatively. This is in contrast with patients who had aortic root replacement with biological or mechanical valves. Anticoagulation-related hemorrhage, thromboembolism and endocarditis remain as serious problems with mechanical heart valves, whereas primary tissue failure and endocarditis remain as the main problems with biological valves. None of these problems appear to be an issue in patients who have aortic valvesparing operations.
As with any type of heart valve repair, the most important adverse effect with aortic valve-sparing operations is valve failure. There is certainly a learning curve with any procedure, and aortic valve-sparing operation is no exception. Initially, we used the reimplantation technique in patients with annuloaortic ectasia, and the remodeling technique in those with normal aortic annulus [5] . The advantage of the reimplantation technique is that it addresses all problems, the dilated annulus, sinuses of Valsalva and sinotubular junction. Its disadvantage is that the aortic valve cusps are placed inside a cylindrical conduit without the sinuses of Valsalva, which may alter their motion and increase mechanical stress. Cochran et al. proposed a modi®cation to the reimplantation technique to create pseudo-sinuses [10] . Yacoub et al. have exclusively used the remodeling procedure, even in patients with the Marfan syndrome [11] . We believe that these patients often have a dilated aortic annulus, and if the remodeling procedure is used, an aortic annuloplasty should be added [5] . After a decade of experience with various types of aortic valve-sparing operations in over 150 patients with ascending aorta and/or aortic root aneurysms, we have learned that the reimplantation technique provides for a more stable valve function than the remodeling procedure in patients with annuloaortic ectasia. Although the number of patients who had reimplantation of the aortic valve is much smaller than those who had remodeling of the aortic root, no patient in the ®rst group has more than mild aortic insuf®ciency after 5±10 years of follow-up.
Because of the excellent functional results obtained with aortic valve-sparing operations in the ®rst 5 years of our experience, we began to expand the indications of these procedures, and included patients with prolapsed aortic cusps due to elongation of their free margin [12] . If one, or even two cusps were slightly elongated, we shortened their length with a double layer 6-0 ePTFE suture [12] . Six of our patients with the Marfan syndrome had aortic cusp-shortening with ePTFE sutures, and after 1±5 years, three patients have none or mild aortic insuf®ciency and three have moderate aortic insuf®ciency. If this type of repair proves durable, many more patients with aortic root aneurysms could have aortic valve-sparing operations instead of aortic root replacement.
Limitations of the study
This is a retrospective study with a small sample size. In addition, patients who had aortic root replacement had a higher prevalence of risk factors and longer follow-up than those who had aortic valve-sparing operations. These variables may have biased our results. It is conceivable that with a larger sample size, ample event rate and a randomized trial, multivariable adjustment might dilute the bene®t seen with aortic valve-sparing operations. This remains to be seen and should provide the hypothesis for a future multicenter collaborative clinical trial.
Conclusions
Aortic valve-sparing operations in patients with the Marfan syndrome are safe and provide excellent clinical results during the ®rst decade of follow-up. Because the feasibility of aortic valve-sparing operations is highly dependent on the quality of the aortic cusps, surgery in patients with the Marfan syndrome should be performed before the aneurysm reaches 55 mm and severe aortic insuf-®ciency develops. We believe that surgery should be considered when the diameter of the aortic root reaches 50 mm and the aortic valve cusps are echocardiographically normal.
